These NSAIDs offer about a 30 percent improvement in pain levels, but fail to fundamentally act on the immune system to stop the inflammatory process, which leads to arthritis.
Ezi NSAID zikunika umnyinyiva okuma-30 eephesenti okudamba kweentlungu, kodwa aziwasebenzi amajoni omzimba ukuze ayekise inkqubo yokukrala ekhokelela kwisifo sokuqaqamba kwamalungu omzimba.